Literature DB >> 12523469

Warfarin and acetaminophen interaction.

Markus G Gebauer1, Karin Nyfort-Hansen, Philip J Henschke, Alexander S Gallus.   

Abstract

A 74-year-old man who was receiving warfarin for atrial fibrillation experienced an abrupt increase in his international normalized ratio (INR) after taking acetaminophen. To investigate this effect, the patient's anticoagulation therapy was stabilized, and he was given acetaminophen 1 g 4 times/day for 3 days. His INR rose from 2.3 before receiving acetaminophen to 6.4 on the day after acetaminophen was discontinued. Warfarin was stopped for 2 days, and the patient's INR returned to 2.0. Warfarin was restarted at the same dosage, and his INR remained within 2.0-3.0 for 6 months. Factor VII activity decreased from 29.4% before acetaminophen therapy to 15.5% when his INR was 6.4, and factor X activity fell from 27.0% to 20.2%. His warfarin plasma concentration was 1.54 microg/ml before acetaminophen compared with 1.34 microg/ml when his INR was 6.4. No significant changes in drug intake, clinical status, diet, or lifestyle were noted. Changes in INR of this magnitude with the addition of another drug during stable anticoagulation therapy suggest a drug interaction. The lack of an increase in warfarin plasma concentration associated with the increased INR suggests a possible pharmacodynamic mechanism for this interaction. Acetaminophen or a metabolite may enhance the effect of oral coumarin anticoagulants by augmenting vitamin K antagonism. Thus, the anticoagulant effect of warfarin may be significantly elevated after only a few days of acetaminophen therapy. Patients receiving warfarin should be counseled to have their INR monitored more frequently when starting acetaminophen at dosages exceeding 2 g/day.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12523469     DOI: 10.1592/phco.23.1.109.31913

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  7 in total

1.  Drug interactions-information, education, and the British National Formulary.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

2.  Adverse interaction of warfarin and paracetamol: evidence from a post-mortem study.

Authors:  Terhi Launiainen; Antti Sajantila; Ilpo Rasanen; Erkki Vuori; Ilkka Ojanperä
Journal:  Eur J Clin Pharmacol       Date:  2009-09-25       Impact factor: 2.953

3.  Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility.

Authors:  Renato D Lopes; John D Horowitz; David A Garcia; Mark A Crowther; Elaine M Hylek
Journal:  Blood       Date:  2011-09-12       Impact factor: 22.113

4.  Interaction between acetaminophen and warfarin in adults receiving long-term oral anticoagulants: a randomized controlled trial.

Authors:  Qian Zhang; Claire Bal-dit-Sollier; Ludovic Drouet; Guy Simoneau; Jean-Claude Alvarez; Sandrine Pruvot; Romain Aubourg; Natacha Berge; Jean-Francois Bergmann; Stéphane Mouly; Isabelle Mahé
Journal:  Eur J Clin Pharmacol       Date:  2010-12-30       Impact factor: 2.953

5.  Paracetamol: a haemorrhagic risk factor in patients on warfarin.

Authors:  I Mahé; N Bertrand; L Drouet; G Simoneau; E Mazoyer; C Bal dit Sollier; C Caulin; J F Bergmann
Journal:  Br J Clin Pharmacol       Date:  2005-03       Impact factor: 4.335

Review 6.  Does paracetamol potentiate the effects of oral anticoagulants?: a literature review.

Authors:  Isabelle Mahé; Charles Caulin; Jean-François Bergmann
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

7.  Using highly variable warfarin dosing to identify patients at risk for adverse events.

Authors:  Lyndonna Marrast; Mary Evans; Al Ozonoff; Lori E Henault; Adam J Rose
Journal:  Thromb J       Date:  2011-10-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.